title: Tumor supernatant from myeloid malignancies inhibits T-cell apoptosis and cell cycle entry independently.
authors: D
authors: D
authors: Milojkovic
authors: A G S
authors: AG
authors: Buggins
authors: S
authors: S
authors: Devereux
authors: N S B
authors: NS
authors: Thomas
authors: G J
authors: GJ
authors: Mufti
mesh_terms: D017209:Apoptosis / Q000187:drug effects* / Q000276:immunology; D002453:Cell Cycle / Q000187:drug effects; D002478:Cells, Cultured; D018920:Coculture Techniques; D017077:Culture Media, Conditioned / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D007376:Interleukin-2 / Q000037:antagonists & inhibitors; D007621:Karyotyping; D007951:Leukemia, Myeloid / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D016271:Proto-Oncogene Proteins c-myc / Q000037:antagonists & inhibitors; D016160:Retinoblastoma Protein / Q000037:antagonists & inhibitors; D013601:T-Lymphocytes / Q000166:cytology / Q000187:drug effects* / Q000276:immunology; D019139:Tumor Escape / Q000276:immunology
chemical_list: D017077:Culture Media, Conditioned; D007376:Interleukin-2; D016271:Proto-Oncogene Proteins c-myc; D016160:Retinoblastoma Protein